Just published in Lancet Global Health, the Tanzanian-Norwegian ProRIDE controlled trial in 2000 newborn babies found that a 4-week course of probiotics did not reduce death or hospitalization, but reduced gut carriage of multidrug-resistant bacteria in the probiotic group.
doi.org/10.1016/s221...